Physician profile
Nirav C Naik
NPI 1437132321
$16,236.90
in general payments reported to CMS, 2019-2025
21 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,519 · 2020: $3,573 · 2021: $3,576 · 2022: $241 · 2023: $3,805 · 2024: $1,133 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,355 · Food and Beverage: $1,973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,355.05 |
| Food and Beverage | $1,973.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,865.59 | 2019-2023 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $2,396.58 | 2019 | |
| Ethicon US, LLC | $559.75 | 2019-2024 | Harmonic, Echelon Flex, Echelon Endopath |
| Tela Bio, INC. | $499.02 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $342.50 | 2021-2025 | Arista |
| Teleflex LLC | $250.04 | 2024 | Titan Sgs |
| Medtronic, INC. | $215.23 | 2021-2024 | Manoscan |
| Lilly USA, LLC | $149.84 | 2024 | Mounjaro, Zepbound, Jardiance |
| Pacira Pharmaceuticals Incorporated | $146.42 | 2021-2025 | Exparel |
| Suture Ease, INC. | $137.50 | 2024 | |
| Applied Medical Resources Corporation | $133.90 | 2019 | |
| Sun Pharmaceutical Industries INC. | $121.82 | 2025 | |
| Organogenesis INC. | $108.12 | 2023 | Puraply Antimicrobial |
| Glaxosmithkline, LLC. | $96.33 | 2021-2022 | |
| Nevro Corp. | $64.00 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $43.55 | 2024 | Grafix Pl |
| Baxter Healthcare | $37.30 | 2020-2023 | Tisseel |
| Acell, INC. | $20.53 | 2019 | |
| Lucid Diagnostics INC. | $19.31 | 2023 | |
| Amgen INC. | $16.61 | 2019 | |
| Tactile Systems Technology INC | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Naik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.